Enimmune corporation (6564.TWO)
TWD 18.95
(-26.41%)
TWD 18.95
(-26.41%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 604.82 Million TWD | -21.97% |
| 2022 | 775.09 Million TWD | 27.05% |
| 2021 | 610.06 Million TWD | -7.23% |
| 2020 | 657.62 Million TWD | 99.66% |
| 2019 | 329.37 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 791.13 Million TWD | 0.0% |
| 2024 Q1 | - TWD | -100.0% |
| 2023 Q3 | 604.82 Million TWD | -15.37% |
| 2023 FY | 604.82 Million TWD | -21.97% |
| 2023 Q2 | 714.67 Million TWD | 0.0% |
| 2023 Q1 | 714.67 Million TWD | -7.79% |
| 2023 Q4 | 604.82 Million TWD | 0.0% |
| 2022 FY | 775.09 Million TWD | 27.05% |
| 2022 Q4 | 775.09 Million TWD | 0.0% |
| 2022 Q3 | 775.09 Million TWD | 0.0% |
| 2021 FY | 610.06 Million TWD | -7.23% |
| 2020 FY | 657.62 Million TWD | 99.66% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -372.348% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 79.15% |
| Level Biotechnology Inc. | 822.67 Million TWD | 26.48% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 9.011% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -10.219% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 84.467% |
| GlycoNex Incorporation | 1.55 Billion TWD | 61.05% |
| VBI | 452.1 Million TWD | -33.781% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 48.575% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 19.202% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -59.854% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 46.657% |
| Visgeneer Inc. | 397.17 Million TWD | -52.282% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 83.959% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 71.986% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 31.511% |
| Neith Corporation | 192.15 Million TWD | -214.763% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 90.073% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -722.245% |
| TaiRx, Inc. | 833.74 Million TWD | 27.457% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 80.401% |
| EirGenix Inc. | 11.16 Billion TWD | 94.582% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -5.529% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 64.679% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 83.184% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 42.424% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -100.918% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -128.532% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -37.09% |
| RBC Bioscience Corporation | 753.79 Million TWD | 19.762% |
| BiOptic Inc. | 613.77 Million TWD | 1.458% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 65.996% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 47.847% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 6.206% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 80.529% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -308.849% |
| NaviFUS Corp. | 490.53 Million TWD | -23.299% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 50.655% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 55.638% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -14.302% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 47.922% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 63.483% |
| AP Biosciences Inc | 890.75 Million TWD | 32.1% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 92.907% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -86.59% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 54.649% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 77.69% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 96.063% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -47.426% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -52.407% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 70.865% |
| TCI GENE Inc. | 1.16 Billion TWD | 48.125% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -105.318% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 55.636% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 35.777% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 13.405% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 84.703% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 84.178% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 50.821% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 89.207% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 43.049% |
| Acepodia, Inc. | 6.81 Billion TWD | 91.13% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 84.194% |